|
Market Closed -
OTC Markets
19:51:25 25/10/2024 BST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
+9,900.00% | +9,900.00% |
| 27/10/21 | Patient Access Solutions, Inc. Introduces CAMEO | CI |
| 24/08/21 | Cara Therapeutics Shares Rise 7% on FDA Approval of Korsuva Injection | DJ |
| Market Cap | 350K 300K 280K 257K 482K 33.47M 488K 3.31M 1.29M 16.81M 1.31M 1.28M 55.61M | P/E 2007 * |
-
| P/E 2008 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 1.39M 1.19M 1.11M 1.02M 1.91M 133M 1.93M 13.12M 5.12M 66.59M 5.2M 5.09M 220M | EV / Sales 2007 * |
-
| EV / Sales 2008 | 24.4x |
| Free-Float |
-
| Yield 2007 * |
-
| Yield 2008 | - |
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0.01 | |
| 10 years | 0 | 0.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Weitzberg
CEO | Chief Executive Officer | 66 | - |
Robert Linzalone
PRN | Corporate Officer/Principal | 66 | 01/02/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/04/26 | Other | 0 | 0% |
| 2007 | 2008 | |
|---|---|---|
| Net sales | 323K 276K 259K 237K 444K 30.87M 450K 3.06M 1.19M 15.51M 1.21M 1.19M 51.29M | 350K 300K 281K 257K 482K 33.52M 489K 3.32M 1.29M 16.84M 1.32M 1.29M 55.7M |
| Net income | -685K -587K -549K -503K -944K -65.57M -956K -6.49M -2.53M -32.94M -2.57M -2.52M -109M | -9.09M -7.79M -7.29M -6.67M -12.52M -870M -12.68M -86.08M -33.57M -437M -34.13M -33.39M -1.45B |
| Net Debt | 1.27M 1.09M 1.02M 935K 1.75M 122M 1.78M 12.06M 4.7M 61.22M 4.78M 4.68M 203M | 1.04M 887K 830K 760K 1.43M 99.09M 1.44M 9.81M 3.82M 49.78M 3.89M 3.8M 165M |
Employees
5
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | US$0.000001 | -.--% | 60,000 |
- Stock Market
- Stocks
- PASO Stock
Select your edition
All financial news and data tailored to specific country editions
















